About this event

  • Date and time Fri 18 Oct 2019 from 8:30am to 18 Oct 2019 at 11:30pm
  • Location Royal Society of Medicine
  • Organised by Urology

This meeting will focus exclusively on benign prostatic conditions, often neglected due to the deserved attention devoted to prostate cancer. 

We will explore both bacterial and non-bacterial prostatitis. Prostatitis is currently extremely poorly managed and this meeting seeks to provide insight into the condition to help improve patient outcomes. We will also explore benign prostatic enlargement, a condition which affects the majority of men over the age of fifty.

This meeting is aimed at consultant and specialist trainee urologists and surgeons. 

This meeting will:

  • Increase the awareness and understanding of prostatitis, in particular, non-bacterial, addressing the aetiology, pathology and management of this difficult condition
  • Discuss the pathophysiology of benign prostatic enlargement
  • Examine the development of treatments for the condition
  • Introduce and discuss the efficacy of some of the newer treatment modalities, many of which have received considerable press attention recently 
  • Help provide guidelines for individually tailored treatment, facilitated by case discussions and debate

 

President's dinner

We invite delegates to join us for a special black-tie dinner which will be held after the meeting at the Royal Hospital Chelsea, Royal Hospital Road, London, SW3 4SR.

Directions to the venue can be found here.

 

We would like to thank our exhibitor:

Sigmacon

Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.

Key speakers

Curtis Nickel

Dr Curtis Nickel

Professor of Urology, Canada Research Chair in Urologic Pain and Inflammation and Urologist, Kingston Health Sciences Centre, Kingston Ontario Canada

Speaker's biography

Dr Nickel is one of the worlds leading experts on prostatitis, in particular, non-bacterial prostatitis including pelvic pain syndromes in men, one of the most common reasons men under fifty consult urologists. Dr Nickel’s clinical and research interests cover inflammatory, benign prostate and pain diseases of the urinary tract. He is Director of the urological chronic pain clinical research clinics in Kingston. He has over 585 publications, is on the editorial board of 8 Urology journals, editor of the AUA Update Series, presented in over 45 countries, currently funded by US NIH and Canadian CRC.  He was president of the Canadian Urological Association in 2017.  He was awarded a The Canadian Institutes of Health Research (CIHR) Tier I Canada Research Chair (until 2022), American Urological Association (AUA) Distinguished Contribution Award, Société Internationale d'Urologie (SIU) Academy Award and in 2018 was the first recipient of the SIU Mostafa Elhilali Award for contributions to international urology research. 

Agenda

View the programme 18 October 2019

Registration, tea and coffee
President's welcome

Session one: Prostatitis

Chairs: Mrs Nadine Coull, Consultant Urologist, Kingston Hospital NHS Foundation Trust and Miss Yaalini Shanmugabavan, ST5 Urology Trainee, Chelsea and Westminster Hospital NHS Foundation Trust

Prostate pathophysiology and BPH development

Prof Richard Bryant, Clinician Scientist Fellow, Cancer Research UK (CRUK), The Royal College of Surgeons of England (RCSEng), Nuffield Department of Surgical Sciences, University of Oxford, Department of Urology, Churchill Hospital and Oxford University Hospitals NHS Foundation Trust, Oxford

Managing chronic prostatitis: 3 decades of painfuly learned insights

Dr Curtis Nickel, Professor of Urology, Canada Research Chair in Urologic Pain and Inflammation and Urologist, Kingston Health Sciences Centre, Kingston Ontario Canada

Genitourinary aspects of chronic prostatitis/chronic pelvic pain syndrome

Dr Paddy Horner, Associate Professor, Sexually Transmitted Infections, University of Bristol and University Hospitals Bristol NHS Foundation Trust

A genital tract microbiome?

Mr Jonathan Ramsay, Consultant Urologist and Andrologist, Imperial College Healthcare NHS Trust

Panel discussion
Tea and coffee break
The microbiology of prostatitis and UTIs

Dr Sophie Collier, Microbiology Consultant, Royal Free London NHS Foundation Trust

Lessons learned! New treatment paradigms in chronic prostatitis

Professor Curtis Nickel

Panel discussion

Benign MDM: Solutions to challenging cases

Lunch

Session two: Benign hyperplasia

Chairs: Mr Mark Speakman, Consultant Urological Surgeon, Taunton and Somerset NHS Trust and Miss Rebecca Tregunna, Robotic Clinical Fellow, Eastbourne District General Hospital

Looking forwards by looking to the past: A brief history of BPH surgery

Mr Jonathan Goddard, Curator of the Museum of Urology, British Association of Urological Surgeons (BAUS) and Consultant Urological Surgeon, Leicester General Hospital

Prostate artery embolisation

Dr Tarun Sabharwal, Consultant Interventional Radiologist, Guy's and St Thomas' NHS Foundation Trust

Greenlight Laser PVP in high risk patients: responding to a changing demographic

Mr Barry Jones, Consultant Urologist, RCSI Hospitals NorthEast, Hermitage Medical Clinic and AutEven Hospital, Dublin, Ireland

REZUM

Professor Hashim Ahmed, Professor of Urology, Imperial College London

UroLift

Professor Thomas McNicholas, Consultant Urological Surgeon, Pinehill Hospital, Hitchin

Panel discussion
Tea and coffee break
HOLEP

Mr Frederick Banks, Consultant Urologist, Watford General Hospital

Aquablation of the prostate – The power of water

Mr Neil Barber, Consultant Urological Surgeon, Frimley Health NHS Foundation Trust

BPH trainee clinical debate: 60 years old 60cc BPH, International Prostate Symptom Score (IPSS) 24/35, Qmax 12mls/sec

Chair: Mr Ben Challacombe, Consultant Urological Surgeon, Guy's and St Thomas' NHS Foundation Trust and Honorary Senior Lecturer, King's College London

Participants: 

UroLift - Hannah Warren 

HOLEP - Arun Sujenthiran 

Green light laser PVP - Thomas Stonier 

Aquablation - Theo Malthouse 

REZUM - Nish Bedi 

PAE - Luke Stroman 

Panel discussion
Conclusions

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom